对STARE的外部验证和时间稳定性分析,STARE是不可逆转的PET标记物的无血液量化工具
bioRxiv : the preprint server for biology
|February 23, 2026
概括
无血液的STARE方法为量化动态18F-氧糖 (18F-FDG) 定子发射断层扫描 (PET) 扫描提供了一个可行的替代方案. 这种方法简化了数据收集和分析,可能增加PET成像的临床可访问性.
科学领域:
- 核医学是一种核医学.
- 医学成像医学成像
- 生物物理学的生物物理.
背景情况:
- 动态18F-氧葡萄糖 (18F-FDG) 定子发射断层扫描 (PET) 图像依赖于基于血液的量化,这是复杂和昂贵的.
- 之前开发的一种无血液方法STARE (源到目标自动旋转估计) 需要在不同的PET扫描仪上进行外部验证.
研究的目的:
- 为外部验证STARE方法用于动态18F-FDG PET数据的无血液量化.
- 评估STARE在不同类型的PET扫描仪 (西门子生物mCT和大脑生物科学CerePET) 的性能.
- 评估STARE和传统的帕特拉克量化方法的时间稳定性.
主要方法:
- 20名参与者在两天接受了60分钟的18F-FDG动态PET扫描,使用Biograph mCT和CerePET扫描仪.
- 使用STARE和基于血液的Patlak方法估计了区域净流入率 (K_i).
- 用20分,30分,40分和50分钟的扫描数据来评估K_i估计的时间稳定性.
主要成果:
- 在Biograph mCT (r=0.93) 上,STARE 与Patlak K_i估计的高相关性以及在CerePET (r=0.71) 上的中等相关性.
- 在Biograph mCT上,STARE从20分钟提供了可靠的K_i估计,但在CerePET上需要50分钟.
- 帕特拉克方法在两台扫描仪上都产生了稳定的K_i估计,从40分钟开始.
结论:
- STARE是一种实用的,非侵入性的替代方案,用于动态的18F-FDG PET量化.
- 这种无血方法可以促进更短的扫描时间,提高患者的舒适度,并可能增加临床采用.
- STARE提供了一种更容易获得的动态18F-FDG PET成像方法.
更多相关视频
10:21Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
Published on: August 8, 2019
8.9K
08:36Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
725
相关概念视频
Effects of EDTA on End-Point Detection Methods
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
